Currently, Repligen Corp [RGEN] is trading at $167.93, down -1.20%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RGEN shares have gain 3.64% over the last week, with a monthly amount glided 3.42%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Repligen Corp [NASDAQ: RGEN] stock has seen the most recent analyst activity on October 01, 2025, when HSBC Securities initiated its Buy rating and assigned the stock a price target of $150. Previously, Evercore ISI upgraded its rating to Outperform on September 22, 2025, and kept the price target unchanged to $155. Barclays started tracking the stock assigning an Overweight rating and suggested a price target of $150 on June 24, 2025. Wolfe Research upgraded its rating to an Outperform but $160 remained the price target by the analyst firm on April 29, 2025. Evercore ISI started tracking with a In-line rating for this stock on March 18, 2025, and assigned it a price target of $155. In a note dated February 10, 2025, TD Cowen initiated a Buy rating and provided a target price of $200 on this stock.
This stock has fluctuated between a low of $102.96 and a high of $182.52 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $181.43 within the next 12 months. Repligen Corp [NASDAQ: RGEN] shares were valued at $167.93 at the most recent close of the market. An investor can expect a potential return of 8.04% based on the average RGEN price forecast.
Analyzing the RGEN fundamentals
Trailing Twelve Months sales for Repligen Corp [NASDAQ:RGEN] were 707.89M which represents 21.91% growth. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at 0.0%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.0. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Repligen Corp [NASDAQ:RGEN] is 8.36. Also, the Quick Ratio is 7.14, while the Cash Ratio stands at 5.71. Considering the valuation of this stock, the price to sales ratio is 13.35, the price to book ratio is 4.54 and price to earnings (TTM) ratio is 6534.24.
Transactions by insiders
Recent insider trading involved DAWES KAREN A, Director, that happened on Dec 17 ’25 when 275.0 shares were sold. Director, DAWES KAREN A completed a deal on Dec 17 ’25 to buy 275.0 shares. Meanwhile, Chief Executive Officer Loeillot Olivier sold 7041.0 shares on Nov 25 ’25.
